- Meeting abstract
- Open Access
HTLV-I and –II seroprevalence among United States blood donors, 2000-2009
© Kaidarova and Murphy; licensee BioMed Central Ltd. 2011
- Published: 6 June 2011
- Prevalence Rate
- Blood Donor
- Birth Cohort
- Cohort Effect
- Educational Achievement
HTLV-I and –II (HTLV-I/II) infection is prevalent at low levels in the United States, but recent reports on HTLV-I/II prevalence among blood donors are lacking.
Computerized data on all first-time blood donors in a large network of United States blood centers was examined during the period 2000-2009. HTLV-I/II antibody was measured by enzyme immunoassay (EIA), with supplemental testing of all reactive samples using an EIA from an alternate manufacturer. Prevalence rates were calculated, and odds ratios (OR) and 95% confidence intervals (CI) for associations with demographic characteristics were assessed using multivariate logistic regression.
Among 1,904,155 first-time blood donors, HTLV-I/II prevalence decreased from 10 per 10,000 in 2000 to 5 per 10,000 in 2009 (p trend < 0.0001). Prevalence increased with age through middle age and then decreased in older age. HTLV-I/II infection was associated with female sex (OR =1.54, 95% CI 1.28-1.85), age 50-59 (OR=10.15, 95% CI 6.16-16.72), Black (OR=5.69, 95% CI 4.38-7.38) and Hispanic (OR=2.59, 95% CI 2.06-3.26) race/ethnicity, and inversely with university education (OR=0.59, 95% CI 0.45-0.76). There was minimal geographic variation, although donors from the southwestern US had slightly higher prevalence.
HTLV-I/II prevalence is decreasing slowly among US blood donors, consistent with a birth cohort effect whereby donors born in the 1950s and 60s had higher prevalence rates compared to younger donors. HTLV-I/II associations with female sex, non-white race and lower educational achievement are consistent with previous studies. With 3.2 million first-time donors annually nationwide, US blood banks detect several hundred HTLV-I/II infections per year.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.